When thinking of insurance giants, New York-based MetLife, Inc. (MET) naturally commands attention. Founded in 1868, the company has built a global footprint, serving millions of customers across more than 40 countries with life, dental, disability, and financial services. Its market capitalization stands at $52.1 billion.
Companies worth $10 billion or more are generally described as “large-cap stocks,” and MetLife is firmly positioned in this category, with its market cap exceeding this threshold, signaling both scale and influence in the insurance and financial services industry. Its straightforward business model, consistent returns on equity, and diversified offerings have earned it a solid reputation.
More News from Barchart
Despite the strengths, MET’s chart tells a mixed story. Shares of MetLife touched a 52-week high of $85.29 on May 22, but since then, shares have slipped 2.2%. Over the past three months, MET has climbed 13.8%, which is impressive – and when comparing that against the S&P 500 Index ($SPX), which has rallied nearly 10.4% in the same period, MET stock has outperformed.
www.barchart.com
Take a wider view, however, and the comparison becomes less favorable. Over the past 52 weeks, shares of MetLife has returned 5.9%, well below the S&P 500’s 27% rally. The gap is evident in 2026 as well, with MET up 5.7% on a year-to-date (YTD) basis versus the index’s 10.8% advance.
Still, the technical picture has improved considerably. After spending much of the spring trading below its key moving averages, MetLife has regained its footing and is trading above both its 50-day and 200-day moving averages since April. That shift suggests buyers have recently regained control, pointing to strengthening bullish momentum heading into the second half of the year.
www.barchart.com
Behind the stock’s recent resilience is a business that continues to fire on multiple cylinders. MetLife has spent years building a diversified insurance and retirement platform, and that breadth is paying off. In the first…
..